Ghost Tree Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

A detailed history of Ghost Tree Capital, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 65,000 shares of APLS stock, worth $2.16 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

65,000

Previous 135,000 51.85%

Holding current value

$2.16 Million

Previous $5.18 Million 63.81%

% of portfolio

0.7%

Previous 2.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $2.02 Million - $2.88 Million	-70,000 Reduced 51.85%	65,000 $1.87 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $190,350 - $298,550	5,000 Added 3.85%	135,000 $5.18 Million
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $7.2 Million - $9.42 Million	130,000 New	130,000 $7.64 Million
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $1.18 Million - $1.44 Million	15,380 Added 9.34%	180,000 $16.4 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $6.31 Million - $9.07 Million	-135,380 Reduced 45.13%	164,620 $10.9 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $1.08 Million - $1.53 Million	25,000 Added 9.09%	300,000 $15.5 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $2.24 Million - $3.48 Million	50,000 Added 22.22%	275,000 $18.8 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $876,750 - $1.48 Million	-25,000 Reduced 10.0%	225,000 $10.2 Million
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $2.66 Million - $4.06 Million	-75,000 Reduced 23.08%	250,000 $12.7 Million
Q4 2021 Feb 16, 2022	BUY	$30.74 - $49.16 $3.84 Million - $6.15 Million	125,000 Added 62.5%	325,000 $15.4 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $6.28 Million - $14 Million	200,000 New	200,000 $6.59 Million
Q2 2021 Aug 11, 2021	SELL	$40.9 - $64.9 $9.2 Million - $14.6 Million	-225,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$40.8 - $57.39 $4.08 Million - $5.74 Million	-100,000 Reduced 30.77%	225,000 $9.66 Million
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $10 Million - $18.6 Million	325,000 New	325,000 $18.6 Million
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $3.13 Million - $7.76 Million	-175,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $3.87 Million - $5.39 Million	175,000 New	175,000 $5.36 Million
Q4 2018 Feb 14, 2019	SELL	$11.47 - $18.71 $2.12 Million - $3.46 Million	-185,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$19.63 - $30.0 $3.63 Million - $5.55 Million	185,000 New	185,000 $4.07 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.65B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History